Boehringer Ingelheim is a leading global, research-driven pharmaceutical company founded in 1885 and headquartered in Germany. As a family-owned business, we are committed to improving the health and quality of life for both humans and animals. With innovation at our core, we develop breakthrough therapies in areas such as cardiometabolic diseases, oncology, respiratory, and immunology. Operating in over 130 countries with a strong focus on sustainability and collaboration, we strive to create long-term value through science that matters.